Tirzepatide is a dual-action agonist for GLP-1 and GIP receptors, intended solely for research purposes. Its robust combination of receptor activity has demonstrated encouraging outcomes in studies focused on weight loss and metabolic health.
Key Benefits:
- For research purposes only
- Dual-action mechanism (GLP-1 and GIP) to enhance metabolic effects
- Available in 10mg, 20mg, and 30mg doses for versatile research
- Perfect for advanced studies on weight loss and metabolic health
- (includes free injection pen)
